Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center